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The origin and nature of the differences between the sexes 
is likely to have been a subject of debate since prehistory. 
Many theories proposed by the ancient philosophers were 
interesting, if inaccurate (the “heat” of lovemaking does 
not determine maleness, as proposed by Aristotle, but the 
temperature of embryonic development is indeed im- 
portant for some species). The debate began to find a 
good scientific basis with the beginning of the chromo- 
some theory early this century. With the advent of modern 
genetics and molecular biology, for many the surprise has 
been that, unlike many basic developmental events, the 
mechanisms employed for sex determination are ex- 
tremely varied. Nearly every type of regulatory mechanism 
known is used in the control of sex determination. Owing 
to this variety, the study of sex determination has provided 
an extremely rich source of information on how regulatory 
switches function in the development of nonsexual as well 
as sexual characters. The first Keystone Symposia on The 
Molecular Basis for Differences between the Sexes took 
place on February 12-18, 1995, at Tamarron, Colorado. 
The topics focused on sex determination and differentia- 
tion in humans, mice, fruit flies, and worms, although an 
interesting session was devoted to sex determination in 
other organisms. Below we review this meeting. 
Primary Determinants of Sex 
In Drosophila melanogaster, Caenorhabditis elegans, and 
mammals, sex is determined chromosomally. For organ- 
isms such as these with XY chromosomal systems, the 
primary sex determinant is related either to the number 
of X chromosomes or the presence of the Y chromosome. 
Both of these types of mechanisms are used. 
Drosophila 
In Drosophila, the primary determinant of sex is the X 
chromosome:autosome ratio (X:A ratio). This ratio is as- 
sessed by a counting process involving the expression of 
X-linked numerator and autosomal denominator elements 
that make up the X:A ratio signal (reviewed by Cline, 1993). 
The target of the X:A signal is the Sex-lethal gene (Sxl), 
which functions as a master switch gene that regulates 
both somatic sexual differentiation and X chromosome 
dosage compensation (and also functions in germline sex 
determination: see below). Early in development, an X:A 
Meeting Review 
ratio of 1 in females is counted and is responsible for ac- 
tivating an embryo-specific Sxl promoter. In males, the 
X:A ratio of 0.5 is too low for activation, and Sxl remains 
“off.” Slightly later in development, Sxl is transcribed in 
both sexes by use of a different promoter, but only makes 
a functional product in females owing to autoregulation 
of its own expression by alternative RNA splicing. Using 
genetic screens based on interactions with the Sxl gene, 
a small number of genes have been identified that function 
as numerator (sisterless a [sis a], sis b, and runt) or denomi- 
nator (deadpan [dpn]) counting elements. In addition, sev- 
eral maternally provided factors function either positively 
(such as daughterless [da] and hermaphrodite [her]) or 
negatively (exrramachrochaefae [emc] and grouch0 [gro]; 
Paroush et al., 1994) in the counting process (see Figure 
1). All of these factors have homology to various classes 
of transcriptional regulatory factors, consistent with the 
fact that regulation of Sxl by the X:A signal is transcrip- 
tional. At the Keystone meeting T. Cline (University of Cali- 
fornia, Berkeley) presented the resultsof further screening 
for numerator and denominator elements. No new numer- 
ator elements have been identified except for the X-linked 
gene sis c, which has a rather weak contribution to numer- 
ator counting. Essentially, no new autosomal elements 
were identified, although 10 new alleles of dpn, which is 
a rather weak denominator element, and a cluster of very 
weak elements on the left arm of the second chromosome 
were picked up by the screen. These results taken to- 
gether suggest that either the autosomal contribution to 
the X:A signal may be a consequence of a lot of scattered 
genes that individually have very minor effects or that it 
plays a relatively minor role in X:A counting and that per- 
haps the denominator includes other factors such as size 
of the nucleus, the mass of DNA, or both. 
C. elegans 
In C. elegans the primary determinant of sex is also the 
X:A ratio. Assessment of this signal leads to the develop- 
ment of XX hermaphrodites (which produce both sperm 
and eggs) and X0 males (reviewed by Parkhurst and 
Meneely, 1994). The molecular nature of the X:A signal 
in C. elegans is currently unknown. However, evidence 
that discrete X:A counting elements exist came from pre- 
sentations from B. Meyer and colleagues (University of 
California, Berkeley). A region at the left end of the X chro- 
mosome appears to contain counting elements, as two 
copies cause X0 lethality and one copy causes XX her- 
maphrodites to be sick (Akerib and Meyer, 1994); both 
phenotypes are apparently due to upsets in dosage com- 
pensation. The dose-sensitive effects of this region are 
likely to be due to counting elements because they act 
upstream of the X0 lethal gene x01-7, the earliest acting 
gene of the sex determination hierarchy (Figure 1). The 
region has been subdivided into three smaller dose sensi- 
tive regions, although to have an effect in XX animals, a 
copy of each of the three regions must be lacking. Signifi- 
cantly, C. Akerib reported the isolation of point mutations 
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Figure 1. Genetic Regulatory Pathways Controlling Somatic Sex Determination and Dosage Compensation 
(Top) D. melanogaster. (Bottom) C. elegans. See text for details. 
in one of these regions (found by suppressing the X0 le- 
thality caused by the X duplications), indicating that count- 
ing involves specific loci. A second approach being used 
to identify counting elements or other factors that function 
upstream of x01-l is based on a xol-1::lacZ reporter con- 
struct, which gives sex-specific /acZ expression in em- 
bryos (presented by J. Kopczynski). Because high levels 
of x01-7 expression result in male development and low 
levels in female development, mutations that result in the 
production of increased numbers of xo/-l::/acZ-express- 
ing embryos are being screened for. Using this approach, 
an X-linked mutation has been isolated (in a region of the 
X different from the duplications discussed above) that 
may also function as a signal element because it sup- 
presses the X0 lethality caused by the X duplications but 
does not suppress x01-7 mutations. Taken together these 
results provide strong evidence that the counting process 
in C. elegans requires multiple discrete signal elements. 
Mammals 
In mammals, the Y chromosome establishes maleness. 
The primary event occurs relatively late during embryo 
development and is active only in the cells that will give 
rise to the gonads. In mice, the gonads first develop as 
thickenings of the primitive kidney or mesonephros, at 
about 10 days postcoitum (dpc) and are identical in fe- 
males and males (this stage is called “indifferent”) until 2 
days later, when morphological differences between the 
sexes can first be observed. The basic gonadal develop- 
mental pathway in mammals is female, but this is overrid- 
den in the male owing to the action of Sry, the gene in the 
sex-determining region of the Y chromosome. Srytriggers 
testis differentiation, and then maleness in the rest of the 
embryo results from the action of the steroid hormone 
testosterone and Miillerian-inhibiting substance (MIS, oth- 
erwise known as anti-Millerian hormone [AMH]), a mem- 
ber of the transforming growth factor 9 (TGFf3) family of 
growth factors, secreted by the testis (see Figure 2). 
Sry is thought to encode a transcription factor as it con- 
tains an high mobility group (HMG) box type of DNA- 
binding domain similar to that found in known transcription 
factors. The DNA-binding domain is highly conserved in 
different species, but the rest of the SRY protein is not 
homologous. Whether this means that the HMG domain 
is the only region of the protein important for function is 
not known. The HMG domain of SRY binds DNA in a se- 
quence-specific manner and introduces a sharp bend in 
the double helix. V. Harley (University of Cambridge) dis- 
cussed evidence showing that mutations in the HMG do- 
main derived from sex-reversed human patients could be 
separated into those affecting DNA binding and those af- 
fecting DNA bending, suggesting that these properties are 
both important in the function of the SRY protein as a 
transcriptional regulator. The HMG domain was also found 
to bind to calmodulin at high affinitites in vitro. The func- 
tional significance of this property is unknown, but it sug- 
gests that SRY activity may be subject to another level of 
control. 
Srywas previously shown to be expressed by germ cells 
in adult mouse testis surprisingly as a circular transcript 
that seems not to be translated (Cape1 et al., 1993). After 
an arduous search, the transcript in the developing gonad 
was found by R. Lovell-Badge (National Institute for Medi- 
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cal Research, London) and colleagues to be a 4.8 kb RNA 
transcribed from a different promoter than that used in the 
adult. Sry is turned on specifically in the genital ridge at 
about 10.5-11 dpc, just before the morphological differ- 
ence between sexes is observed and is turned off at about 
12.5 dpc. Sry is therefore functioning to initiate the path- 
way of testis differentiation rather than to maintain it. Ft. 
Lovell-Badge also proposed that it functions as a compe- 
tence factor, consistent with observations that in some 
cases Sry expression fails to commit cells to the male 
pathway. Conversely, ovarian tissuecan transdifferentiate 
to testicular structures in certain circumstances in the 
complete absence of Sry. 
The Regulatory Hierarchies Controlling 
Somatic Sexual Differentiation 
In the last 15 years, tremendous progress has been made 
in the understanding of the regulatory hierarchies that 
transmit the primary sex-determining signal in Drosophila 
and C. elegans. The power of genetics has led to the identi- 
fication of many genes essential to somatic sexual differ- 
entiation that have been ordered into multistep regulatory 
hierarchies (see Figure 1). Interestingly, the ways in which 
the pathways operate are quite different. In Drosophila 
the hierarchy functions cell autonomously and involves a 
positive regulatory cascade of alternative RNA processing 
decisions, whereas the C. elegans regulatory hierarchy 
involves a negative cascade that is not completely cell 
autonomous. The situation in mammals is not as well char- 
acterized. Several genes that are thought to be involved 
in sex determination have been recently identified, but the 
establishment of a hierarchy is still to come. 
Drosophila 
Recent biochemical studies on the Drosophila hierarchy 
have demonstrated that the pathway contains no gaps; 
the proteins encoded by the genes that make up the core 
of the hierarchy (Sxlthrough doublesex [dsx]) directly regu- 
late the expression of the gene at the next level in the 
hierarchy (reviewed by McKeown and Madigan, 1992). 
This part of the hierarchy involves a cascade of alternative 
RNA processing decisions, while the top (activation of Sxi) 
and the bottom of the hierarchy (the downstream function 
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of dsx) involve transcriptional regulatory mechanisms. As 
both RNA splicing and transcription are complex pro- 
cesses involving many factors, a detailed understanding 
of the mechanisms involved at each step in the hierarchy 
entails elucidation of how the products of these regulatory 
genes interact with the basic cellular machinery. Several 
factors that interact with the hierarchy have been identified 
(presentation by L. Ryner, Stanford University). For exam- 
ple, the hergene is an essential gene that shows tempera- 
ture-sensitive maternal and zygotic sex-specific pheno- 
types (Pultzand Baker, 1995). Genetic analysis hasshown 
that her functions both at the top and the bottom of the 
hierarchy. The sequence of her was reported, revealing 
the presence of zinc fingers, suggesting a role for her as 
a transcription factor. Such a role is consistent with the 
two places in the hierarchy where her functions. 
Up to a few years ago, it was thought that all aspects 
of somatic sexual development were controlled through 
dsx, as it lies at the bottom of the regulatory hierarchy. 
However, this notion has changed owing to the discovery 
made by Taylor (1992), who found that the development 
of a male-specific muscle (muscle of Lawrence [MOL]) 
was not controlled by dsx but was controlled by genes 
upstream in the hierarchy. This result suggested that there 
is a previously unrecognized branch to the regulatory hier- 
archy just downstream of transformer (tra) and tra-2. L. 
Ryner presented data suggesting that the gene that lies 
at the top of this newly identified branch is the fruitless 
(fru) gene. fru contains the same regulatory sequences 
found in dsx, and mutants of fru show MOL defects, as 
expected for a gene functioning in this branch (Gailey et 
al., 1991). Interestingly, the fru branch controls sex- 
specific aspects of nervous system function, as MOL de- 
velopment depends on innervation by male-specific motor 
neurons, and fru mutants exhibit male-specific courtship 
defects. 
Two presentations addressed the specific functions of 
the fru and dsx branches of the hierarchy. B. Taylor (Ore- 
gon State University) discussed the role of the fru branch 
in controlling cellular and developmental aspects of MOL 
development. A primary target of control appears to be 
the recruitment of myoblasts to the developing MOL. K. 
Burtis (University of California, Davis) discussed several 
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properties of dsx. dsx produces sex-specific polypeptides 
that function as a transcriptional regulators and control 
the development of most Sexually dimorphic traits, al- 
though yolk protein genes are the only known direct tar- 
gets (reviewed by Burtis and Wolfner, 1992). Information 
on the biochemical properties of dsx molecules was pre- 
sented, including the identification of a palindromic con- 
sensus-binding site and evidence of dimerization between 
dsx molecules. In addition, an allele-specific interaction 
between dsx and intersex (ix) (another gene required for 
female-specific differentiation) was reported, suggesting 
a possible physical interaction between the proteins of 
these genes. Last, several promising methods currently 
being used to look for downstream targets of dsx were 
described. 
C. elegans 
In C. elegans, most of the genes in the pathway have been 
cloned, but direct interactions among the genes have not 
yet been demonstrated. It was evident from the meeting 
that significant progress has been made toward an under- 
standing of each step of the hierarchy. 6. Meyer (Univer- 
sity of California, Berkeley) discussed the genes that act 
at the beginning of the hierarchy that coordinately control 
both sex determination and dosage compensation. x07-7, 
the earliest acting gene, functions as a genetic switch: 
high levels of x0/-7 triggers male development and low 
levels permit hermaphrodite development (Rhind et al., 
1995). x07-7 directs male development by negatively regu- 
lating one or more of the sex determination and dosage 
compensation (sdc) genes. Molecular data suggest that 
sdc-2 is the likely target of x0/-7. Evidence for this was 
presented by B. Meyer, who reported that a sdc-2::lacZ 
construct is sex-specifically expressed dependent on the 
activity of x0/-7, suggesting that regulation is transcrip- 
tional. The next gene downstream of the sdc genes in 
the sex determination branch of the hierarchy is her-7. M. 
Perry (University of Toronto) discussed the analysis of 32 
extant her-7 alleles that mapped to all parts of the gene, 
including several that mapped to the promoter region. Two 
of these appear to define a promoter site that is involved 
in the negative regulation of her-7, perhaps by one of the 
sdc genes. Three other alleles are single base changes 
in the promoter that cause temperature-sensitive loss of 
her-7 function. Temperature shift experiments reveal that 
her-7 is required to specify male sexual fate later in devel- 
opment than was previously thought, from embryogenesis 
into the Ll larval stage. In addition, her-7 was shown to 
have a maintenance function in adults asX0 males shifted 
to the restrictive temperature begin to synthesize her- 
maphrodite-specific yolk proteins. her-7 encodes a small 
cysteine-rich secreted protein that may well be a ligand 
for the product of the next gene downstream, tra-2, which 
encodes an integral membrane protein. This possible in- 
teraction between HER-l and TRA-2 may account for the 
nonautonomy of sex determination in C. elegans. The 
genes downstream of fra-2 are the fern genes that, based 
on their position in the hierarchy between fra-2 and tra-7, 
may transduce the signal from Pa-2 in the cytoplasmic 
membrane to tra-7 in the nucleus. J. Hodgkin (Medical 
Research Council Laboratory for Molecular Biology, Cam- 
bridge, England) discussed a possible mechanism for reg- 
ulation of tra-7. Strikingly, of 30 gain-of-function tra-7 al- 
leles that have been isolated, 29 affect a small stretch of 
amino acids at the N-terminus, suggesting that this is a 
site of negative regulation (de Bono et al., 1995). Because 
the fern genes negatively regulate Pa-l, their protein prod- 
ucts are obvious candidates for interactions with this re- 
gion, in particular FEM-1, as it contains six ankyrin re- 
peats, a domain found in other proteins involved in 
protein-protein interactions. 
Several presentations dealt with the downstream func- 
tions of tra-7. The rra-7 gene makes two transcripts, one 
that encodes a protein with five zinc fingers and the other 
a truncated version with only the first two of the zinc fingers 
(Zarkower and Hodgkin, 1992). Only the larger TRA-1 pro- 
tein binds DNA in vitro and is thought to be either a nega- 
tive or positive transcription factor (or both) that regulates 
a number of downstream targets involved in directing her- 
maphrodite development. However, it has been proposed 
that the smaller protein could serve to titrate factors that 
negatively regulate TRA-1, perhaps through interactions 
with the N-terminal domain discussed above. Possible tar- 
gets of TRA-1 are being sought both by looking for genes 
that have specific roles in the development of sex-specific 
structures and by using the TRA-1 DNA-binding consen- 
sus (Zarkower and Hodgkin, 1993) to screen the C. eleg- 
ans sequence data base for possible targets. Candidate 
genes have been identified by both of these means. One 
possible candidate is the male abnormal gene mab-3 (pre- 
sented by J. Hodgkin; D. Zarkower, University of Minne- 
sota Medical School). mab-3 functions downstream of 
tra-7, and mab3 mutants are feminized in more than one 
tissue type, indicating that mab-3 has a regulatory func- 
tion. The regulatory nature of mab-3 suggests that it has 
a relatively upstream position in the sexual developmental 
program and therefore may be a direct target of TRA-1. 
S. Emmons (Albert Einstein College of Medicine), who 
is studying the morphogenesis of the specialized mating 
structure of the male tail, has identified several genes that 
are required for ray morphogenesis (rays are peripheral 
sense organs of the male tail). One of these, /in-32, is a 
particularly good candidate for a direct target of TRA-1 for 
two reasons. First, ectopic expression of LIN-32 over- 
comes regulation by the hierarchy and results in the ec- 
topic production of ray precursors in hermaphrodites, indi- 
cating that /in-32 functions downstream of tra-7. Second, 
a potential TRA-l-binding site is found in the promoter 
region of /in-32. Interestingly, the ectopic expression result 
indicates that /in-32 is sufficient to direct epidermal cells 
into neural fates, which is consistent with /in-32 being a 
homolog of a Drosophila gene of the achaete-scufe com- 
plex (a set of genes involved in Drosophila neurogenesis). 
Proof of direct interactions between TRA-1 and potential 
targets awaits biochemical studies. 
Mammals 
Little is known about the molecular nature of gonadal dif- 
ferentiation in mammals, although there is substantial 
knowledge of the cellular processes that occur during early 
testis and ovary development. The first cell type to be 
determined in the developing genital ridge by the action 
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of Sryare the Sertoli cells, and they in turn direct the differ- 
entiation of the other cell types in the testis (Burgoyne et 
al., 1988). The timing during development of Sry action is 
critical, as shown in the case of the late-acting Y chromo- 
some from the poschiavinus subspecies of Mus musculus 
domesticus, which fails to induce testis formation in cer- 
tain genetic backgrounds. E. Either (Jackson Labora- 
tories, Bar Harbor, ME) and colleagues have mapped the 
autosomal loci involved in this effect to chromosomes 2, 
4, and 5. The Sty gene is normally necessary and sufficient 
to determine a testis, but nothing is known about the genes 
it regulates to produce this effect. Studies by K. McEI- 
reavey (Institut Pasteur, Paris) and colleagues on human 
XY females and XX males have led to the postulate that 
SRY acts as a repressor of a negative regulator of testis 
development. What thesefactorsare is not known. Human 
sex-reversed patients have been the main source of infor- 
mation on candidate sex determination genes. The estab- 
lishment of epistatic relationships between these genes 
and SRY, however, must await their analysis in the mouse. 
The gene for a severe dwarfism syndrome, campomelic 
dysplasia, often associated with XY female sex reversal, 
has been cloned by A. Schafer (University of Cambridge) 
and colleagues and by others (Wagner et al., 1994; Wright 
et al., 1995). The gene encodes a protein with a DNA-binding 
domain related to that of SRY and has been named SOX9. 
The phenotypes of these patients are associated with inac- 
tivating mutations within the open reading frame of SOX9 
or with translocations at some distance upstream of the 
gene. These mutations are present in only one allele of 
the gene, suggesting that sex reversal and campomelic 
dysplasia in these patients could be due to haploinsuffi- 
ciency of the SOX9 gene product. Where this gene fits in 
the sex determination pathway is unknown, and studies 
in the mouse are underway. 
Another case of dosage-sensitive sex reversal in hu- 
mans is found in XY females that have a duplication in a 
region of the short arm of the X chromosome. One model 
for this effect assumes that this region contains a gene, 
termed DSS for dosage-sensitive sex reversal, which en- 
codes a female specific function. This would normally be 
negatively regulated by SRY in males, but this repression 
fails when the gene is present in a double dose and not X 
inactivated. A gene that encodes a member of the nuclear 
hormone receptor superfamily has been cloned from this 
region. This gene has been implicated in the condition 
known as adrenal hypoplasia congenita (AHC) and has 
therefore now been named DAX-7 for DSS-AHC critical 
region on the X chromosome (Zanaria et al., 1994). A. 
Swain (National Institute for Medical Research, London) 
showed that DAX-7 isexpressed in thegenital ridge in mice 
at 11.5 dpc, consistent with a role in sex determination, but 
apparently at similar levels in both females and males. If 
it is to be a candidate for a female-specific function that 
is negatively regulated in males any repression must be 
posttranscriptional (see Figure 2). 
Studies in mice on another member of the nuclear hor- 
mone receptor superfamily, the steroidogenic factor 1 
(SF7) gene, has shown that it is involved in gonad develop- 
ment and possibly in sex determination. The SF7 gene 
was first identified as a factor that regulates steroidigenic 
enzymes in the adrenal cortex and gonads. However, SF7- 
deficient mice generated by K. Parker (Duke University) 
and colleagues showed a complete absence of gonads 
as well as adrenals, implying that the gene has a function 
in the initial development of these organs before Sry is 
turned on. Mice lacking the Wilms tumor gene (WT7), a 
transcription factor involved in kidney development, also 
show a lack of gonad development (Figure 2) but K. Parker 
reported that this seems to be in a pathway independent 
of SF7. SF7 has further links to reproduction, as the SF7- 
deficient mice did not express multiple markers of the go- 
nadotrope lineage and lacked theventromedial hypothala- 
mic nucleus, a region implicated in reproductive behavior. 
SF7 has also been implicated in sex determination be- 
cause of its sexually dimorphic expression in the gonad. 
Although SF7 transcripts are present in both sexes from 
early in mouse development, the levels decline in females 
at about 12 dpc, when morphological differences are oc- 
curring (Luo et al., 1994). Furthermore, studies in vitro 
have shown that the SF1 protein can bind to the upstream 
region of the gene encoding Amh, one of the first known 
markers of Sertoli cells, and activate transcription in co- 
transfection assays (Shen et al., 1994). However, because 
it is expressed earlier and in both sexes, SF7 alone cannot 
account for the testis-specific activation of Amh expres- 
sion at 11.5 dpc. Several studies have implied that Sty 
does not directly activate AMH but acts through an uniden- 
tified factor (C. Hagg, Massachusetts General Hospital). 
Cell movements between the mesonephros and the go- 
nad are also important in testis formation (Buehr and 
McLaren, 1993). B. Cape1 (Duke University) presented data 
that showed that the migration from the mesonephros to 
the gonad seems to be greater in an XY versus an XX 
gonad, highlighting the importance of cell-cell signaling 
in testis differentiation. Factors that mediate this kind of 
signaling have not been identified. Differential patterns of 
expression in the male mouse gonad at the time when 
Sry is thought to act are found for Amh and for desert 
hedgehog, a member of a family of proteins that are known 
to be important in cell signaling. However, mice deficient 
in either of these genes do not show a phenotype consis- 
tent with a role in sex determination (Behringer et al., 1994; 
M. Bitgood, Harvard University). R. Behringer (M. D. An- 
derson Cancer Center, Houston, TX) presented work on 
transgenic and mutant mice that showed that Amh is re- 
sponsible for the regression of the mullerian ducts and 
suggested that it might be involved in the control of prolifer- 
ation of steroidogenic cells in the testis. 
Dosage Compensation 
Dosage compensation is the process by which the levels of 
X-linked gene expression is equalized between the sexes. 
Like other aspects of sex determination, the strategies 
used to accomplish this are varied. In fact, the model sys- 
tems fruit flies, worms, and mammals each use a different 
mechanism. 
Drosophila 
In Drosophila, dosage compensation is achieved by ele- 
vating the levels of transcripts that are produced from the 
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single X chromosome in males to the level of transcripts 
produced by both Xs in females (reviewed by Baker et al., 
1994). Four genes that are involved in dosage compensa- 
tion have been isolated based on the male-specific lethal 
effects of mutant alleles: m&l, msl-2, msl-3, and m/e, col- 
lectively called the msls. All four msl genes have been 
cloned, with the molecular characterization of msl-2 being 
reported at this Keystone meeting (presentation by M. Kur- 
oda, Baylor College of Medicine; also reported by 6. 
Baker, Stanford University, and J. Lucchesi, Emory Uni- 
versity). Through the use of antibodies directed against 
each of the msl proteins, it has been shown that each of 
the msls is localized to hundreds of specific sites along the 
length of the X chromosome in males, but not in females, 
suggesting that the msls are direct mediators of dosage 
compensation and that they may work together to regulate 
the same set of X-linked genes. In addition, an isoform of 
histone H4 acetylated at Lys-16 (H4Acl6) also associates 
mainly with the male X chromosome. The X chromosome 
binding of each of the msls and H4Ac16 depends on the 
wild-type function of all the msls, suggesting that these 
gene products may associate with one another in a hetero- 
merit complex. Biochemical evidence for such an inter- 
action was presented by M. Kuroda, who reported coim- 
munoprecipitation of msl-1 and msl-2 from male larval 
extracts. 
How is dosage compensation controlled in Drosophila? 
Several lines of evidence indicate that Sxl negatively regu- 
lates dosage compensation by preventing hypertranscrip- 
tion of the females X chromosomes. In addition, genetic 
data are consistent with Sxlfunctioning as an on/off switch 
to control dosage compensation as it does to control so- 
matic sexual differentiation (Cline, 1984); however, con- 
flicting data on this point are present in the literature (re- 
viewed by Lucchesi and Manning, 1987). Recently, using 
specific polyclonal antibodies, the association of the msls 
and H4Ac16 with the X chromosome has been examined 
in flies that are mosaic for Sxl expression. This analysis 
has shown that, at the cellular level, there is a perfect 
inverse correlation of Sxl expression and msl association 
with the X chromosome, indicative of Sxl functioning as an 
on/off switch to control dosage compensation (reviewed by 
Baker et al., 1994). The same type of analysis has been 
used to examine whether 2X:3A intersexes are intermedi- 
ate in their expression of X-linked genes owing to mosa- 
icism (some cells “on” and some cells “off”) or owing to 
intermediate levels of hypertranscription in each cell. At 
the meeting B. Baker reported that, indeed, 2X:3A in- 
tersexes are mosaics for msl binding, providing direct evi- 
dence that Sxl works as an on/off switch to control dosage 
compensation. A. Hilfiker (Emory University) discussed 
the role of Sxl and virilizer (vir), another gene known to be 
involved in sex determination, in dosage compensation. 
He found that the activity of vir is required for female- 
specific splicing of Sxl transcripts and that certain combi- 
nations of virand Sxlalleles lead to X chromosome associ- 
ation of msls in larval tissues of XX females, but that these 
same animals can develop into normal, viable female 
adults. 
Sxl could negatively regulate dosage compensation by 
“turning off” the expression of one of the msls. M. Kuroda 
presented data showing that msl-2 protein appears to be 
male specific (the other msls are detected in both sexes) 
and that ectopic expression of msl-2 in females leads to 
accumulation of the other msls on the females X chromo- 
somes and decreased viability, both signs of upsets in 
dosage compensation. These results indicate that msl-2 
behaves as a dosage compensation switch gene and is 
good candidate for the target of Sxl regulation. Because 
Sxl functions as an RNA-binding protein that regulates 
RNA splicing decisions to control somatic sexual differen- 
tiation, it is reasonable to expect that control of dosage 
compensation should occur through a similar mechanism. 
J. Lucchesi reported that a sex-specific alternative RNA 
splicing event occurs in the S’untranslated region (SUTR) 
of msl-2 transcripts: an intron that is removed in males 
and retained in females has consensus Sxl-binding sites 
near the two splice junctions, suggesting that splicing of 
the intron is dependent on the activity of Sxl (Zhou et al., 
1995). In addition, M. Kuroda presented evidence that se- 
quences in the msl-2 B’UTR also contribute to the sex- 
specific expression of ms/-2, suggesting that Sxl may do 
more than just control RNA splicing. 
C. elegans 
In C. elegans, dosage compensation is accomplished by 
reducing the expression of X-linked genes in XX hermaph- 
rodites. Five genes, dpy-21, dpy-26, dpy-27, dpy-28, and 
dpy-30, have been identified that function in the dosage 
compensation process. Mutations in these genes kill or 
enfeebleXX hermaphrodites. Noneof these genes, except 
dpy-30, is required in X0 animals, and all, except for dpy- 
27, are required maternally in XX embryos. As in Drosoph- 
ila, dosage compensation and sex determination are coor- 
dinately controlled by the sex determination hierarchy. In 
XX animals the sdc genes control both processes by acti- 
vating dosage compensation and repressing the male- 
specific sex determination genes. Until very recently, rela- 
tively little was known about how the sdc and dpy genes 
control dosage compensation. The recent molecular clon- 
ing and characterization of dpy-27 has led to significant 
insights into this problem. 
DPY-27 is a member of the expanding SMC family of 
proteins involved in chromosome condensation (Chuang 
et al., 1994). Antibodies against DPY-27 show a diffuse 
nuclear staining in both XX and X0 oocytes and early 
embryos. However, the staining becomes localized to the 
X chromosome in XX embryos at the 30-cell stage (and 
in X0 embryos that activate the XX mode of dosage com- 
pensation). These resultssuggest that dpy-27maydirectly 
regulate dosage compensation by influencing higher order 
chromosome structure of the X chromosome that could 
result in a reduction of X-linked gene expression (Chuang 
et al., 1994). Data regarding how regulation of dosage com- 
pensation is achieved were presented by P.-T. Chuang 
(University of California, Berkeley). By looking at DPY-27 
staining in various mutant backgrounds, it was shown that 
X chromosome localization of DPY-27 requires the wild- 
type activity of sdc-2, sdc3, and dpy-30. Because sdc-2 
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appears to be required zygotically and is expressed specif- 
ically in hermaphrodites, sdc-2 may be the sex-specific 
factor required for DPY-27 X chromosome localization. 
In addition, dpy-26 and dpy-28 may be required for the 
production or stability of DPY-27 as staining is severely 
reduced in these mutant backgrounds. Interestingly, 
SDC3 may also be localized to the X chromosome. Based 
on this and the fact that SDC-3 contains a pair of zinc 
fingers, it was suggested that SDC-3 might be the factor 
that confers X chromosome specificity to DPY-27. It is 
clear from these types of analyses that a mechanistic 
model for the dosage compensation process in C. elegans 
will be forthcoming in the near future. 
Mammals 
Dosage compensation is achieved by inactivating one of 
the two X chromosomes in the female. The process of X 
inactivation is controlled by a &acting locus termed the 
X inactivation center (XIC). The Xist gene maps to the XIC 
region on the mouse and human X chromosome and is 
expressed only from the inactive X, making it a strong 
candidate for XIC itself. The gene encodes a 15 kb tran- 
script in mouse that shows several regions of high se- 
quence similarity with the human transcript, but it does not 
contain any significant or conserved open reading frame 
(reviewed by Rastan, 1994). The Xist RNA could be the 
functional unit in the process of X inactivation, but it is 
formally possible that it is merely the act of transcribing 
the gene that is important. In support of the former, H. 
Willard (Case Western Reserve University) presented data 
showing that Xist RNA interacts with the inactive X, appar- 
ently along most of its length, in interphase nuclei, but 
intriguingly it is dispersed during mitosis. It is not known 
whether it reassociates after mitosis or whether only na- 
scent transcripts are able to bind. The chromatin compo- 
nents with which it interacts are presently unknown. 
Expression of the Xist gene just precedes the onset of 
X inactivation in mouse development, and it is thought to 
be involved in the initiation of inactivation. To study the role 
of Xist in this process, N. Brockdorff (Medical Research 
Council Clinical Science Centre, Cambridge) and col- 
leagues used gene targeting by homologous recombina- 
tion to create XX embryonic stem (ES) cells with a 7 kb 
deletion at the beginning of the Xist transcription unit in 
one X chromosome. XX ES cells have two active X chro- 
mosomes; upon differentiation, random X inactivation oc- 
curs. The targeted cells showed cytological X inactivation 
after differentiation, and Xist was expressed from the nor- 
mal X suggesting that the deletion does not affect the initial 
signal that “counts” the number of X chromosomes. The 
targeted ES cells contained X chromosomes from widely 
different mouse strains, such that polymorphisms could 
be used to distinguish transcripts from several genes 
along the deleted and normal X and therefore assess the 
state of X inactivation. The results suggested that the tar- 
geted cells differentiate into two populations, those that 
select the normal X for inactivation undergoing normal X 
inactivation and those that select the targeted X failing to 
inactivate. The data strongly suggest that Xi.9 transcripts 
are required in cis to inactivate genes along the X, but not 
for the counting process. 
Sex Determination in the Germline 
The generation of sperm and eggs is perhaps the most 
essential aspect of sex-specific differentiation for sexual 
reproduction, yet studies of germline sex determination 
have lagged behind studies of other aspects of sexual 
differentiation. The primary reason for this seems to be 
that sex-transformed germ cells are not as easily detected 
as sex-transformed somatic structures. Nonetheless, sig- 
nificant progress has been made in recent years toward 
a molecular understanding of germline sex determination. 
Drosophila 
In Drosophila, the sex of germ cells is determined by both 
autonomous and inductive signals (reviewed by Stein- 
mann-Zwicky, 1992). Evidence from experiments in which 
XX and XY germ cells are transplanted into hosts of the 
opposite sex have shown that the sex of XX germ cells is 
determined by an inductive signal from the gonadal soma. 
However, XY germ cells are unresponsive to this signal: 
they are male irrespective of their environment. The genes 
that control somatic sex determination do not determine 
the sex of the germline, with the exception of Sxl, whose 
product is required in germ cells for oogenesis. Further- 
more, the factors that make up the X:A ratio and function 
to initiate Sxl expression in the soma (such as sis a, sis 
b, and da) do not have this same function in the germline. 
In addition, Sxl seems to be required relatively late for 
oogenesis, at metamorphosis (Steinmann-Zwicky, 1994). 
This leaves several open questions. What is the role of 
Sxl in the germline? How is Sxlactivated in ovaries? What 
are the factors that control sex determination in the germ- 
line? And when do they act? 
Three presentations at the meeting dealt with answering 
these questions. First, T. Cline showed that in the germline 
Sxl does not operate as a genetic switch like it does in 
the soma: Sxl activity in the germline is not sufficient to 
direct XY germ cells into the oogenic pathway, even in 
the context of a feminized soma. Second, he showed that 
Sxl autoregulation, the process by which the Sxl protein 
directs the splicing of its own transcript into a protein ex- 
pressing form in the soma, also occurs in the germline. 
However, Sxl germline autoregulation does not depend 
strictly on somatic inputs nor the germline X:A ratio, sug- 
gesting that the control point for Sxl function in the germ- 
line is not through the autoregulation process itself but 
instead lies at an initiation step. Interestingly, Sxl expres- 
sion in the germline may be, in part, directly controlled by 
the dose of X-linked factors that are involved in regulating 
Sxl RNA splicing. 
Second, B. Oliver (Centre National de la Recherche Sci- 
entifique, Marseille) discussed the role of ovo in germline 
sex determination. ovo functions upstream of Sxl in a 
germline regulatory hierarchy and is specifically required 
for XX germ cell viability. However, the lethality of XX germ 
cells observed in ovo mutants is partially suppressed by 
mutations in the dosage compensation gene m/e, sug- 
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gesting a possible role for ovo in germ cell dosage compen- 
sation (Oliver et al., 1993). Interestingly, ovo appears to 
be sex-specifically regulated as ovo::/acZ constructs are 
expressed at high levels in females and low levels in 
males. 
Third, M. Steinmann-Zwicky (University of Zurich) dis- 
cussed the timing of sex determination in the germline 
and suggested that while Sxl is a target of an inductive 
signal from the soma, it may not be the initial determinant 
of sex in the germline. Germ cells first display sexual di- 
morphism during embryogenesis, when Sxl is not yet re- 
quired for germ cell sex determination. Therefore, to study 
the initial aspects of germline sex determination, M. 
Steinmann-Zwicky is studying enhancer trap lines that are 
expressed in the gonads of young animals. One line is 
particularly useful as it is expressed only in stem cells of 
the male germline and can be detected during embryogen- 
esis. Studies with this marker suggest that both inductive 
and autonomous signals operate already in embryogene- 
sis and that the sex of germ cells is reversible until fairly 
late in development. 
C. elegans 
In contrast with Drosophila, sex determination in the germ- 
line of C. elegans uses all the same genes that are used for 
sex determination in the soma, with acoupleof differences 
(reviewed by Parkhurst and Meneely, 1994). These in- 
clude, first, that the fern genes may act at the bottom of 
the germline pathway to bring about spermatogenesis di- 
rectly, instead of through the down-regulation of fra-7. Sec- 
ond, the function of tra-7 in the germline is more complex 
than in the soma and appears to have a role in gametogen- 
esis in both sexes. In addition, several genes have been 
identified that function specifically in germline sex determi- 
nation (the mog and fog genes, named for masculinizing 
and feminizing of the germline). However, the specific 
functions of these genes are presently unknown. 
Hermaphrodite development can be viewed as essen- 
tially female development with a short period of male germ- 
line development to produce sperm before oogenesis en- 
sues. To achieve spermatogenesis in hermaphrodites, 
tra-2 is transiently inactivated in the gonad. One way this 
is thought to occur is by translational repression of tra-2. 
tra-2 contains two direct repeats in its 3’lJTR (termed the 
DREs, for direct repeat elements) known to be necessary 
for translational repression (Goodwin et al., 1993). A possi- 
ble candidate for the factor that binds the DREs and re- 
presses translation was discussed by E. B. Goodwin 
(Northwestern University). The gene, called laf-7 (for lethal 
and feminizing), was isolated as a dominant suppressor 
of the mogphenotype and is homozygous lethal. Two lines 
of evidence were presented that suggest that laf-7 is re- 
sponsible for modulation of tra-2 translation: laf-7 appears 
to act upstream of Pa-2 in a genetic pathway, and ectopic 
expression of a IacZ reporter construct containing the 
DREs is observed in a laf-7/+ background, indicating that 
laf-7 is required for translation repression through the 
DREs. Interestingly, epistasis tests of laf-7 with tra-7 and 
tra-2 suggests that tra-7 and tra-2 may act in parallel in- 
stead of in the generally accepted linear pathway and that 
Pa-7 may not be the sole terminal regulator in the sex 
determination pathway. However, further experiments are 
required to test these suggestions. 
T. Schedl (Washington University) discussed the func- 
tion of g/d-l (defective in germline development), a tumor 
suppressor gene required for oocyte development (Fran- 
cis et al., 1995). Germ cells of g/d-l-null mutant hermaph- 
rodites enter meiosis normally but then return to mitosis 
at the pachytene stage and form germline tumors where 
oocytes normally form. When the pathway is set in the 
male mode, these oocytes develop into sperm, indicating 
that g/d-l function is not essential for spermatogenesis. 
However, g/d-l may function to promote spermatogenesis 
in hermaphrodites and may have a nonessential role in 
regulating germ cell proliferation in both sexes. Molecular 
analysis of g/d-l was reported at the meeting and reveals 
that g/d-l expression is germline specific and the product 
is apparently cytoplasmic. It contains a region with similar- 
ity to mammalian Sam68 (Src associated in mitosis protein 
~68) that includesan RNA-binding KH domain, suggesting 
that the way that g/d-l functions is by effecting translation 
or transcript stability of target mRNAs. 
Mammals 
The sexual phenotype of germ cells in mammals is not 
dependent on the genotype of the germ cells but on the 
sex of the surrounding gonadal tissue. In the mouse, at 
about 10-l 1 dpc germ cells migrate into the genital ridge, 
where they proliferate for 2-3 days before they first begin 
to show sex differences. In the ovary, germ cells enter 
meiosis and then arrest at the prophase of the first meiotic 
division. In the testis the germ cells enter mitotic arrest at 
about 13 days. The germ cells then resume proliferation 
after birth, not entering meiosis until much later. P. Bur- 
goyne (National Institute for Medical Research, London) 
discussed what he called meioticquality control, a process 
that operates when chromosomes remain unpaired during 
meoisis. By looking at mice that were male because they 
have part of the Y chromosome that includes Sry attached 
to the X, but lack the pairing region, it was possible to 
show that the process operates via apoptosis. 
Mouse germ cells that have migrated into other organs 
such as adrenals (in either a female or male embryo) enter 
meiotic arrest whether they are XX or XY. This suggests 
that the testis is producing a mitotic inhibitor substance. 
The molecular nature of this factor is not known. A. 
McLaren (University of Cambridge) described reaggrega- 
tion studies to test whether there may also be a meiosis- 
inducing substance; in these studies, germ cells from the 
gonads were taken at different stages of development and 
cultured with cells from various sources, including lung. 
The germ cells derived from female and young male (10.5- 
11.5 dpc) gonads entered meiosis in the lung cultures 
at about the same time they would do so in the ovary, 
arguing that if a meiotic inducer is necessary for germ 
cell development, it is not a gonad/adrenal-specific fac- 
tor. In these cultures, germ cells derived from older testis 
(12.5 dpc or more) entered mitotic arrest, indicating that 
germ cells in the testis become committed to mitotic arrest 
in the testis to a period between 11.5 and 12.5 dpc. These 
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experiments also suggested that germ cells have a cell 
autonomous timing system to enter meiosis that is only 
overridden if they are located in the testis. 
Not much is known about factors that control sexual 
differences in the germ cells, although growth factors that 
affect germ cell survival, proliferation, and migration have 
been identified. The steel (9) gene product, a mast cell 
growth factor, and its receptor (encoded by the W locus) 
are known to be needed for proper migration and prolifera- 
tion. P. Donovan (Applied Biosystems Bbsic Research 
Program, Frederick, Maryland) described two alleles of the 
SI locus in mice. In SI 77H, which is a mutation in the cyto- 
plasmic tail of this transmembrane growth factor, the males 
are sterile owing to degeneration of spermatogonia, but 
the females are fertile. In SI panda, where regulation of 
the gene is affected, the males are fertile and the females 
are sterile owing to a failure in the maintenance of the 
follicle cells that surround the germ cells. 
Sex Determination in Other Systems 
A session was dedicated to sex determination in organ- 
isms other than the well-studied Drosophila, C. elegans, 
and mice. These studies reinforce how varied the mecha- 
nisms can be and how extrapolation between systems is 
a dangerous business. 
House Fly 
A. Dubendorfer (University of Zurich) reviewed the sit- 
uation for the house fly, Musca domestica, where sex 
is determined by the presence of a dominant male- 
determining factor M and is independent of dosage com- 
pensation. M is usually found on the Y chromosome but 
in some strains can be autosomal. It is thought that M acts 
early and transiently in development to repress a gene, 
F, that is continuously required for female development. 
Transplantation experiments showed that germ cell sex 
determination in these animals is dependent on the sur- 
rounding soma and not on its genotype, like the situation 
in the mouse. A homolog to Drosophila Sxl has been ob- 
served in Musca, but it is expressed in both females and 
males, suggesting that it might not have a fundamental 
role in sex determination. 
Marsupials 
Marsupial testis formation is dependent on the presence 
of the Y chromosome like eutherian mammals. M. Renfree 
(University of Melbourne) reported on the characterization 
of the homolog of Sry in these animals. The expression 
was found not to be restricted to gonadal tissues and re- 
mains “on” for much longer than seen in the mouse. How- 
ever, this is also to true for humans and may not reflect 
a marsupial-eutherian dichotomy. An intriguing difference 
in sex determination observed between marsupials and 
eutherian mammals is that several structures, such as the 
scrotum in males and the pouch and mammary primordia 
in females, develop before gonadal differentiation is com- 
plete. Interestingly, these dimorphic characteristics are 
under the direct control of the X chromosome and indepen- 
dent of the Y. The identities of the X-linked genes involved 
in this process are not known. 
Spotted Hyena 
P. Licht (University of California, Berkeley) reviewed the 
case of the female spotted hyena that displays many exter- 
nal characteristics that are identified with maleness in 
mammals. They have no Vagina, as the vaginal labia have 
fused to form a pseudoscrotum, and they have a structure 
that looks like a penis through which they urinate, copu- 
late, and give,birth. The behavior of these females is highly 
aggressive and dominant right !rom birth. In mammals, 
male secondary sexual characteristics are regulated by 
testosterone produced by the testis. Female hyenas have 
lower levels of testosterone than the normal levels seen 
in males but have higher androstenedione, an intermedi- 
ate in the testosterone production pathway. When females 
are pregnant, this androstenedione is converted to testos- 
terone by the placenta and transferred to the fetus. The. 
hyena placenta does not have the protective mechanisms 
seen, for example, in humans that prevent testosterone 
reaching and masculininzing the fetus. Hyena fetuses 
were treated with an anti-androgen drug, but surprisingly 
thefemalesdid not lose their masculine traits, although the 
males were affected as they showed phalluses resembling 
those seen on females. It is clear that hyenas have the 
last laugh. 
Fern 
In the fern Ceratopteris richardii, the determinant of sex 
is the pheromone antheridiogen (Ace), which acts by pro- 
moting male development of the haploid spore. In the ab- 
sence of Ace, spores develop as hermaphrodites. These 
produce and secrete Ace that will determine the sex of the 
surrounding slower germinating spores as males. Abscisic 
acid blocks the Ace response in these plants. J. Banks 
(Purdue University) described various classes of muta- 
tions that affect sex determination and response to Ace 
and abscisic acid. The epistatic relationship between 
these mutations was elegantly presented showing the be- 
ginnings of a hierarchy in the establishment of sexual dif- 
ferences in Ceratopteris. The molecular nature of these 
factors is not yet known. 
Evolution of Sex Chromosomes 
B. Charlesworth (University of Chicago) discussed several 
mechanisms of how sex chromosomes could have evolved. 
The switch from the ancient cosexual state to dioecy in- 
volves the occurrence of two mutation steps: a male steril- 
ity mutation converting cosexuals into females and a fe- 
male sterility mutation converting cosexuals into males. 
Assuming an initial recessive male sterility mutation, a 
subsequent dominant female sterility mutation will occur 
that must be located at a closely linked locus to avoid 
recombination to give individuals with male and female 
sterility. This series of events would create the proto-X 
chromosome that could carry the female fertility and male 
sterility genes and the proto-\/ chromosome with the fe- 
male sterility and male fertility genes. Selection for differ- 
ences between the sexes would follow and determine the 
reduced genetic exchange over a wide region between 
the proto-X and proto-\/. A consequence of the lack of 
recombination will be the accumulation of deleterious mu- 
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tations, transposable elements, and tandem DNA repeats 
on the proto-Y leading to a chromosome that is different 
to the X and is genetically inert, except for the sex-specific 
function. The accumulation of deleterious mutations on 
the proto-\/ could be due to a stochastic process (Mullet+ 
ratchet) or could spread by association with favorable 
Y-linked mutant alleles (hitchhiking model). In either case, 
the activity of the X in the regions not related to sexual 
functions is increased relative to the Y in the heteroga- 
metic sex and a system for dosage compensation must 
then evolve. 
J. Graves (La Trobe University) discussed how studying 
sex chromosomes in marsupials and monotremes has pro- 
vided valuable information on mechanisms of evolution. 
There is high homology between the X and Y in these 
animals, consistent with the proposal that the sex chromo- 
somes evolved from a homologous pair of autosomes. In 
marsupials, only the paternally derived X is inactivated, 
a possible intermediate in the process that gave rise to the 
random X inactivation system seen in eutherian mammals. 
The long arm and proximal short arm of the X chromosome 
show conserved positions of loci between marsupials and 
humans, implying that this region was present in the an- 
cestral X. In contrast, loci on the short arm of the human 
X, which includes the pseudoautosomal or pairing region 
where recombination between the X and Y occurs, map 
to two clusters of autosomal loci in marsupials and mono- 
tremes. This suggests that the short arm of the X was cre- 
ated by addition of a piece of an autosome to the ancestral 
X. A homolog to SRY is found on the marsupial Y but not 
as yet in monotremes, implying that this gene has a recent 
evolutionary history. The wider expression pattern seen 
for the marsupial SRY gene compared with that in euthe- 
rian mammals led J. Graves to suggest that it could reflect 
the expression of the ancestral gene from which SRY 
evolved. This is thought to be the gene SOX3, which, of 
the many SOX genes being found, is closest to SRY in 
terms of sequence within its HMG box DNA-binding do- 
main and is also X linked in both marsupial and eutherian 
mammals. 
Closing Remarks 
This is a time of rapid progress in the field of sex determina- 
tion. Because of the diversity of mechanisms used to con- 
trol sex determination, lessons learned from the study of 
various model organisms should continue to surprize and 
remind us of the importance of sex. We congratulate B. 
Baker, R. Lovell-Badge, and B. Meyer for organizing such 
a stimulating meeting. A special thanks goes to B. Baker 
and Ft. Lovell-Badge for their help and support during the 
writing of this review. We also thank I. Marin, B. Meyer, and 
all the other presenters who commented on the review. 
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